We are live on ! Find out more
Nisa Investment Advisors

Nisa Investment Advisors Portfolio holdings

AUM $32B
1-Year Est. Return 32.86%
This Fund
S&P 500
This Quarter Est. Return
+12.76%
1 Year Est. Return
+32.86%
3 Year Est. Return
+108.44%
5 Year Est. Return
+138.89%
10 Year Est. Return
+505.54%
AUM
$22.2B
AUM Growth
+$2.18B
Cap. Flow
+$152M
Cap. Flow %
0.68%
Top 10 Hldgs %
45.51%
Holding
3,133
New
154
Increased
1,313
Reduced
1,267
Closed
93

Top Sells

Rank Stock Value
1
NVDA icon
NVIDIA
NVDA
+$65.6M
2
GOOG icon
Alphabet (Google) Class C
GOOG
+$61.6M
3
QCOM icon
Qualcomm
QCOM
+$59.1M
4
CME icon
CME Group
CME
+$58M
5
BKNG icon
Booking.com
BKNG
+$54.4M

Sector Composition

Rank Sector Weight
1 Technology 24.54%
2 Financials 10.86%
3 Communication Services 7.23%
4 Consumer Discretionary 7.21%
5 Industrials 6.98%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
AVD icon
2651
American Vanguard Corp
AVD
$65.5M
$1.56K ﹤0.01%
398
+329
+477% +$1.37K
SMLR
2652
DELISTED
Semler Scientific
SMLR
$1.55K ﹤0.01%
40
+7
+21% +$249
GPRO icon
2653
GoPro
GPRO
$121M
$1.54K ﹤0.01%
2,036
+744
+58% +$483
AMTX icon
2654
Aemetis
AMTX
$120M
$1.54K ﹤0.01%
621
+189
+44% +$320
VSTM icon
2655
Verastem
VSTM
$615M
$1.52K ﹤0.01%
367
-890
-71% -$5.58K
CERS icon
2656
Cerus
CERS
$508M
$1.52K ﹤0.01%
1,079
+82
+8% +$109
CRMT icon
2657
America's Car Mart
CRMT
$26.1M
$1.51K ﹤0.01%
27
+17
+170% +$842
SEPN
2658
Septerna Inc
SEPN
$1.75B
$1.51K ﹤0.01%
143
+9
+7% +$74
GALT icon
2659
Galectin Therapeutics
GALT
$315M
$1.51K ﹤0.01%
716
MLAB icon
2660
Mesa Laboratories
MLAB
$569M
$1.51K ﹤0.01%
16
-5
-24% -$549
HOWL icon
2661
Werewolf Therapeutics
HOWL
$18.6M
$1.5K ﹤0.01%
+1,375
New +$1.42K
FRPH icon
2662
FRP Holdings
FRPH
$415M
$1.48K ﹤0.01%
+55
New +$1.49K
IRWD icon
2663
Ironwood Pharmaceuticals
IRWD
$669M
$1.47K ﹤0.01%
2,051
-367
-15% -$288
OCGN icon
2664
Ocugen
OCGN
$444M
$1.47K ﹤0.01%
+1,510
New +$1.25K
HOV icon
2665
Hovnanian Enterprises
HOV
$772M
$1.46K ﹤0.01%
14
-21
-60% -$2.06K
PACK icon
2666
Ranpak Holdings
PACK
$446M
$1.46K ﹤0.01%
410
+401
+4,456% +$1.49K
NC icon
2667
NACCO Industries
NC
$312M
$1.46K ﹤0.01%
33
TRC icon
2668
Tejon Ranch
TRC
$445M
$1.46K ﹤0.01%
86
ALT icon
2669
Altimmune
ALT
$593M
$1.46K ﹤0.01%
376
+9
+2% +$49
LCTX icon
2670
Lineage Cell Therapeutics
LCTX
$286M
$1.44K ﹤0.01%
1,589
+661
+71% +$392
PAMT
2671
PAMT Corp
PAMT
$287M
$1.44K ﹤0.01%
112
+21
+23% +$282
HNST icon
2672
The Honest Company
HNST
$561M
$1.44K ﹤0.01%
282
-116
-29% -$556
GRDN
2673
Guardian Pharmacy Services
GRDN
$2.63B
$1.43K ﹤0.01%
67
UAA icon
2674
Under Armour
UAA
$2.5B
$1.43K ﹤0.01%
209
-826
-80% -$5.14K
ABOS icon
2675
Acumen Pharmaceuticals
ABOS
$176M
$1.43K ﹤0.01%
+1,229
New +$1.32K

Similar funds

Nisa Investment Advisors's Q2 2025 Portfolio in Review

As of Q2 2025, Nisa Investment Advisors held 3,133 positions worth $22.2B, up 11% from $20B the previous quarter. Its ten largest holdings account for 46% of the portfolio.

Nisa Investment Advisors's Q2 2025 filing shows 154 new, 1,313 increased, 1,267 reduced and 93 closed positions. Its largest new stake was iShares Core US Aggregate Bond ETF: 3,987,632 shares worth $396M. The largest sale was NVIDIA, an estimated $65.6M.

By sector, the portfolio is most concentrated in Technology at 25% of assets, up from 24% a quarter earlier, followed by Financials and Communication Services.

  • Nisa Investment Advisors's largest Q2 2025 buy was iShares Core US Aggregate Bond ETF: 3,987,632 shares worth $396M.
  • Nisa Investment Advisors added most to iShares Core S&P 500 ETF in Q2 2025, an estimated $611M increase.
  • Nisa Investment Advisors's biggest Q2 2025 reduction was NVIDIA, cutting an estimated $65.6M.
  • Nisa Investment Advisors fully exited Vanguard FTSE All-World ex-US Small-Cap Index Fund in Q2 2025, selling an estimated $24.3M.
  • Nisa Investment Advisors's ten largest holdings make up 46% of its $22.2B portfolio in Q2 2025.
  • Nisa Investment Advisors opened 154 new positions and closed 93 in Q2 2025.
  • Nisa Investment Advisors's portfolio value rose 11% quarter-over-quarter to $22.2B.

Based on Nisa Investment Advisors's 13F filing for Q2 2025, filed 31 Jul 2025.